Veterinary Medicines

Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water

Authorised
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate
Download as PDF

Product identification

Medicine name:
Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water
Lincoral-S 222 mg/g + 444,7 mg/g poudre pour administration dans l'eau de boisson pour porcs et poulets
Lincoral-S 222 mg/g + 444,7 mg/g poeder voor gebruik in drinkwater voor varkens en kippen
Lincoral-S 222 mg/g + 444.7 mg/g Pulver zum Eingeben über das Trinkwasser für Schweine und Hühner
Active substance:
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate
Target species:
  • Chicken
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lincomycin hydrochloride monohydrate
    251.70
    milligram(s)
    /
    1.00
    gram(s)
  • Spectinomycin sulfate tetrahydrate
    672.40
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        5
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • 1.5 kg thermos-sealed bags made of polyethylene/aluminum/polyester
  • 150 g thermos-sealed sachets made of polyethylene/aluminum/polyester

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma S.A.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V661779
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0668/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Greece
  • Hungary
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download
Dutch (PDF)
Published on: 12/10/2023
Download
French (PDF)
Published on: 12/10/2023
Download
German (PDF)
Published on: 12/10/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 12/10/2023
Download
French (PDF)
Published on: 12/10/2023
Download
German (PDF)
Published on: 12/10/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 12/10/2023
Download
French (PDF)
Published on: 12/10/2023
Download
German (PDF)
Published on: 12/10/2023
Download

ie-puar-mr-iev0668001-lincoral-s-222-mgg--4447-mgg-powder-for-use-in-dri-en.pdf

English (PDF)
Published on: 26/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."